US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi U.S. Biotech 2x Daily ETF

39.83

+0.97482.51%

Post-market: 38.85-0.9748-2.45%16:10 EDT

Volume:185

Turnover:7K

Market Cap:597.42K

PE:- -

High:39.83

Open:38.85

Low:39.83

Close:38.85

52wk High:42.22

52wk Low:25.26

Shares:15.00K

Float Shares:15.00K

Volume Ratio:0.29

T/O Rate:1.23%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

NeuroThera Labs Wins Japanese Patent for Next-Generation Pain and Fever Therapy

Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial

Grail announces FDA advisory committee meeting to review Galleri test PMA

European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading

MT Newswires Live

AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape

Recce Pharmaceuticals Seeks ASX Quotation for Advisory Fee Shares

Thalia Therapeutics Updates Voting Rights as RNA Therapy Pipeline Advances

PharmAla reports Q3 revenue C$513,000 vs. C$135,000 last year

Kazia Therapeutics Files Provisional Patent Backing New Paxalisib Strategy in High-Risk Early TNBC

Opening Day: Scribe Therapeutics makes strong trading debut

Oppenheimer would own Capricor Therapeutics into committee meeting

Healios Secures AMED Funding to Industrialize iPSC-Derived NK Cell Therapy

Chinese biotech overtakes AI as emerging-market growth trade

Srinivasan Sivabalan / Bloomberg

BB Biotech posts strong interim profit and shifts to yield-based dividend policy

NeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS

Biotech IPO gains crush AI listings with standout 55% return

Anthony Hughes / Bloomberg

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/XBIX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","market":"US","secType":"STK","nameCN":"Corgi U.S. Biotech 2x Daily ETF","latestPrice":39.8282,"timestamp":1788379200000,"preClose":38.8534,"halted":0,"volume":185,"hourTrading":{"tag":"盘后","latestPrice":38.8534,"preClose":39.8282,"latestTime":"16:10 EDT","volume":4,"amount":159.3128,"timestamp":1788379804683,"change":-0.9748,"changeRate":-0.024475,"amplitude":0},"delay":0,"changeRate":0.025089181384383395,"floatShares":15000,"shares":15000,"eps":0,"marketStatus":"Closed","change":0.9748,"latestTime":"09-02 16:00:00 EDT","open":38.8534,"high":39.8282,"low":39.8282,"amount":7360,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":5,"adr":0,"exchange":"CBOE","adjPreClose":38.8534,"nav":38.9,"aum":583500,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.8534,"preClose":39.8282,"latestTime":"16:10 EDT","volume":4,"amount":159.3128,"timestamp":1788379804683,"change":-0.9748,"changeRate":-0.024475,"amplitude":0},"volumeRatio":0.294586},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","floatShares":15000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.294586,"shares":15000,"dividePrice":0,"high":39.8282,"amplitude":0,"preClose":38.8534,"low":39.8282,"week52Low":25.2639,"pbRate":"--","week52High":42.2188,"institutionHeld":0,"latestPrice":39.8282,"eps":0,"divideRate":0,"volume":185,"delay":0,"ttmEps":0,"open":38.8534,"prevYearClose":25.42,"prevWeekClose":38.5006,"prevMonthClose":38.5461,"prevQuarterClose":37.7974,"fiveDayClose":41.5039,"twentyDayClose":34.6838,"sixtyDayClose":25.2639},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBIX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBIX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBIX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658700929","title":"NeuroThera Labs Wins Japanese Patent for Next-Generation Pain and Fever Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658700929","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658700929?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:08","pubTimestamp":1786540125,"startTime":"0","endTime":"0","summary":"NeuroThera Labs Inc. ( ($TSE:NTLX) ) has issued an update. NeuroThera Labs Inc., a clinical-stage biotech and majority-owned subsidiary of SciSparc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-wins-japanese-patent-for-next-generation-pain-and-fever-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurothera-labs-wins-japanese-patent-for-next-generation-pain-and-fever-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","XBIX","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658930455","title":"Vertex Stock (VRTX) Soars 7% as Rival Sionna (SION) Crashes 92% on Failed Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658930455","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658930455?lang=en_us&edition=fundamental","pubTime":"2026-08-10 23:55","pubTimestamp":1786377312,"startTime":"0","endTime":"0","summary":"Shares of American biotech company Vertex Pharmaceuticals ($VRTX) jumped about 7% on Monday after its top rival Sionna Therapeutics ($SION) reporte...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/vertex-stock-vrtx-soars-7-as-rival-sionna-sion-crashes-92-on-failed-drug-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/vertex-stock-vrtx-soars-7-as-rival-sionna-sion-crashes-92-on-failed-drug-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBBQ","LU1035775433.USD","IE0002141913.USD","GNMX","LU0566484027.USD","LU2362540622.SGD","LU2362541513.USD","LU2237438978.USD","BBH","LU0432979614.USD","IE00BJT1NW94.SGD","LU1430594728.SGD","LU2324357040.USD","XBIX","LU2468319806.SGD","BK4533","LU0417517546.SGD","IE00BFTCPJ56.SGD","LU0061475181.USD","IE00B19Z3B42.SGD","IE00B4R5TH58.HKD","LU2417539215.USD","IE00B19Z9P08.USD","TBXU","BK4532","LU1093756325.SGD","LU0058720904.USD","NVIB","BIB","LU0823416689.USD","VERX","IE00B19Z9Z06.USD","BK4585","LU2462157665.USD","IDNA","LU0079474960.USD","PBE","LU1815336091.USD","IBB","SGXZ57979304.SGD","BK4588","IE00B2B36J28.USD","LU2362541273.HKD","LU2456880835.USD","LU0757428866.USD","BK4139","LU0889565916.HKD","VRTX","LU1674673428.USD","SION"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642727","title":"Grail announces FDA advisory committee meeting to review Galleri test PMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642727","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642727?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115445,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","IBRN","XBIX","BBP","BK4129","BK4588","LABU","BK4585","PMA","GRAL","FBT","PBE","BK4139","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657653126","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2657653126","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657653126?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:18","pubTimestamp":1786029491,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were heading higher late Thursday morning, rising 0.85% to 1,947.79 on the S&P Europe Select ADR Index.From continental Europe, the g","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4077","IEUR","BDRX","BK4139","IE00BFMHRM44.USD","BK4551","BK4568","BNTX","BK4559","BK4117","BK4585","DEO","MEDI","BK4588","BBVA","CLLS","NVIB","TRVG","WPP","BK4082","TRIB","BK4204","BK4107","BK4207","WPP.AU","LU0889565916.HKD","BK4535","CRTO","EVAX","AUTL","BK4111","DGE.UK","PSO","BK4169","LU0320765992.SGD","MREO","BK4009","ASND","BK4548","BK4023","EPV","XBIX","LFGY","OPRA","SNN","BK4505","LU0109394709.USD","AFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167771958","title":"AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape","url":"https://stock-news.laohu8.com/highlight/detail?id=1167771958","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167771958?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:33","pubTimestamp":1785713585,"startTime":"0","endTime":"0","summary":"AstraZeneca PLC (AZN.US) has been in early-stage discussions about acquiring Bristol-Myers Squibb (BMY.US), a move that could create one of the world's largest pharmaceutical companies, according to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1992135399.USD","LU2462157665.USD","LU2089984988.USD","LU0321505439.SGD","LU2125154778.USD","RXL","LU2237443895.HKD","LU0114720955.EUR","LU1868836591.USD","LU2456880835.USD","LU0882574055.USD","IHE","XPH","IE00B3T34201.USD","LU1032466523.USD","LU1868836914.USD","LU0109394709.USD","LU2237443978.SGD","LU0310800379.SGD","LU1983299246.USD","LU1868837136.USD","LU2242652126.USD","IE00BJJMRZ35.SGD","LU2272731865.HKD","LU2417539215.USD","MEDI","IE0002141913.USD","IE00B2B36J28.USD","LU1571399168.USD","IE00BJT1NW94.SGD","PPH","BK4568","BK4588","LU0868494617.USD","LU1093756168.USD","LU2242646821.SGD","IE00BFXG1179.USD","BMY","LU0320765992.SGD","LU0128525929.USD","LU1868836757.USD","LU2237443549.SGD","LU0456855351.SGD","LU1670710661.SGD","BK4559","LU2596442595.SGD","LU2236285917.USD","CURE","LU1291159041.SGD","LU1261432733.SGD","LU1585245621.USD","BK4585","LU1670711123.USD","BK4532","IE00B5TLWC47.USD","LU2322448957.HKD","BK4581","PILL","IE00BSNM7G36.USD","LU1883839398.USD","LU0225771236.USD","AZN","JHMH","LU0061475181.USD","LU0432979614.USD","LU2237443465.HKD","LU1829250122.USD","FXH","LU1992135472.HKD","LU2322448791.USD","LU0289739699.SGD","LU0058720904.USD","LU2468319806.SGD","LU1323610961.USD","FTXH","LU2272731782.SGD","FHLC","LU1267930573.SGD","LU1718418525.SGD","LU0267386448.USD","LU2237443622.USD","LU0029864427.USD","BK4007","LU2473716301.USD","LU2237443382.USD","LU1430594728.SGD","RXD","XBIX","LU2133065610.SGD","LU0306807586.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4534","LU0708994859.HKD","LU0321505868.SGD","LU2125154935.USD","IEHS","LU0096364046.USD","SYNB","LU0985481810.HKD","LU1868837300.USD","LU2360032135.SGD","AZNH","LU0306806265.USD","LU1074936037.SGD","LU0237698245.USD","LU2272731600.USD","LU0225284248.USD","LU1670710588.SGD","LU1670711040.USD","LU0889565916.HKD","LU1989771016.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656457133","title":"Recce Pharmaceuticals Seeks ASX Quotation for Advisory Fee Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2656457133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656457133?lang=en_us&edition=fundamental","pubTime":"2026-08-03 06:42","pubTimestamp":1785710561,"startTime":"0","endTime":"0","summary":"Recce Pharmaceuticals Ltd. ( ($AU:RCE) ) just unveiled an announcement. Recce Pharmaceuticals Ltd., an Australian biotech company listed on the ASX...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recce-pharmaceuticals-seeks-asx-quotation-for-advisory-fee-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recce-pharmaceuticals-seeks-asx-quotation-for-advisory-fee-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655035713","title":"Thalia Therapeutics Updates Voting Rights as RNA Therapy Pipeline Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2655035713","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655035713?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:12","pubTimestamp":1785492749,"startTime":"0","endTime":"0","summary":"An update from N4 Pharma ( ($GB:THAT) ) is now available. Thalia Therapeutics plc, an AIM-listed clinical-stage biotech specialising in RNA-based t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/thalia-therapeutics-updates-voting-rights-as-rna-therapy-pipeline-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/thalia-therapeutics-updates-voting-rights-as-rna-therapy-pipeline-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009354923.USD","NVIB","BK4588","BK4505","BK4585","RNA","BBC","BK4139","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655030638","title":"PharmAla reports Q3 revenue C$513,000 vs. C$135,000 last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2655030638","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655030638?lang=en_us&edition=fundamental","pubTime":"2026-07-30 22:00","pubTimestamp":1785420050,"startTime":"0","endTime":"0","summary":"“PharmAla’s (MDXXF) financial position continues to improve compared to 2025, in line with the broader growth of the biotech industry,” said Nick K...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pharmala-reports-q3-revenue-c513000-vs-c135000-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pharmala-reports-q3-revenue-c513000-vs-c135000-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","NVIB","MDXXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654001714","title":"Kazia Therapeutics Files Provisional Patent Backing New Paxalisib Strategy in High-Risk Early TNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2654001714","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654001714?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:57","pubTimestamp":1785239835,"startTime":"0","endTime":"0","summary":"An update from Kazia Therapeutics ( ($KZIA) ) is now available. Kazia Therapeutics Limited, a Sydney-based oncology biotech listed on Nasdaq, is de...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kazia-therapeutics-files-provisional-patent-backing-new-paxalisib-strategy-in-high-risk-early-tnbc?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kazia-therapeutics-files-provisional-patent-backing-new-paxalisib-strategy-in-high-risk-early-tnbc?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","LCLG","BK4007","XBIX","CANC","BK4539","NVIB","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654730049","title":"Opening Day: Scribe Therapeutics makes strong trading debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2654730049","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654730049?lang=en_us&edition=fundamental","pubTime":"2026-07-27 23:25","pubTimestamp":1785165946,"startTime":"0","endTime":"0","summary":"Scribe Therapeutics makes its public debut above issue price as the CRISPR drug developer opened for trading last week. The biotech entered the mar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opening-day-scribe-therapeutics-makes-strong-trading-debut-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opening-day-scribe-therapeutics-makes-strong-trading-debut-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","SYNB","LU1861559042.SGD","IPOS","BK4611","BK4588","BK4139","BK4556","LU1861558580.USD","ARKG","CRSP","NVIB","SCTX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654045069","title":"Oppenheimer would own Capricor Therapeutics into committee meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2654045069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654045069?lang=en_us&edition=fundamental","pubTime":"2026-07-27 22:20","pubTimestamp":1785162008,"startTime":"0","endTime":"0","summary":"After briefing documents for this Wednesday’s FDA advisory committee for deramiocel became available this morning, Oppenheimer analyst Leland Gersh...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oppenheimer-would-own-capricor-therapeutics-into-committee-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oppenheimer-would-own-capricor-therapeutics-into-committee-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPY","SBIO","BK4139","LABU","BBP","BK4127","BK4585","BBH","FBT","XBIX","BK4588","CAPR","IBRN","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654509632","title":"Healios Secures AMED Funding to Industrialize iPSC-Derived NK Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654509632","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654509632?lang=en_us&edition=fundamental","pubTime":"2026-07-27 10:52","pubTimestamp":1785120734,"startTime":"0","endTime":"0","summary":"Healios KK ( ($JP:4593) ) has issued an update. Healios K.K., a clinical-stage regenerative medicine biotech in Japan, is developing stem cell-base...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healios-secures-amed-funding-to-industrialize-ipsc-derived-nk-cell-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healios-secures-amed-funding-to-industrialize-ipsc-derived-nk-cell-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","BK4135","BK4196","JP","AMED","LU1093756325.SGD","LU1093756168.USD","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654047803","title":"Chinese biotech overtakes AI as emerging-market growth trade","url":"https://stock-news.laohu8.com/highlight/detail?id=2654047803","media":"Srinivasan Sivabalan / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654047803?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:33","pubTimestamp":1785105227,"startTime":"0","endTime":"0","summary":"As the artificial-intelligence rally sputters in emerging markets, investors searching for high-growth alternatives are turning to Chinese biotech.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/healthcare/chinese-biotech-overtakes-ai-emerging-market-growth-trade?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/healthcare/chinese-biotech-overtakes-ai-emerging-market-growth-trade?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["XBIX","VTHR","QQQW","QTOC","AIPO","NVIB","AGIX","CHAT","KURE","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653270989","title":"BB Biotech posts strong interim profit and shifts to yield-based dividend policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2653270989","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653270989?lang=en_us&edition=fundamental","pubTime":"2026-07-24 13:34","pubTimestamp":1784871252,"startTime":"0","endTime":"0","summary":"The latest announcement is out from BB Biotech ( ($CH:BION) ). BB Biotech AG, a specialist biotech investment company listed in Switzerland and Ger...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bb-biotech-posts-strong-interim-profit-and-shifts-to-yield-based-dividend-policy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bb-biotech-posts-strong-interim-profit-and-shifts-to-yield-based-dividend-policy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","US30Y.BOND","US2Y.BOND","XBI","US3Y.BOND","LEAD","VIG","US5Y.BOND","BK4581","US6M.BOND","BK4097","BK4585","BK4547","XBIX","US7Y.BOND","US10Y.BOND","US12M.BOND","BK4588","TMF","TLT","TLTW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653768188","title":"NeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2653768188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653768188?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:56","pubTimestamp":1784725011,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd. ( ($NRSN) ) just unveiled an update. NeuroSense Therapeutics, a late-stage clinical biotech developer of neurodegenera...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurosense-moves-primec-toward-health-canada-drug-submission-for-als?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurosense-moves-primec-toward-health-canada-drug-submission-for-als?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653784051","title":"Biotech IPO gains crush AI listings with standout 55% return","url":"https://stock-news.laohu8.com/highlight/detail?id=2653784051","media":"Anthony Hughes / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653784051?lang=en_us&edition=fundamental","pubTime":"2026-07-21 12:57","pubTimestamp":1784609865,"startTime":"0","endTime":"0","summary":"The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/us-stocks/biotech-ipo-gains-crush-ai-listings-standout-55-return?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/us-stocks/biotech-ipo-gains-crush-ai-listings-standout-55-return?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["VTHR","BK4588","IPOS","QTOC","QQQJ","XBIX","AIPO","PEVC","REDS","BK4585","AGIX","LRCY","NVIB","IJT","CHAT","TMFX","XBI","BKIV","KI","BK4127","FRHC","KCE","IPO","BK4581","ARTY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":36,"code":"91000000","status":"200"}]}}